Stock listing

NASDAQ:ANDS Anadys Pharmaceuticals Inc Stock

Follow Anadys Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ANDS

$3.70 USD

Close on Nov 23, 2011 · No longer trades

Mar 26, 2004 to last close -47.6% · weekly closes, Mar 26, 2004 – Nov 23, 2011
Lowest – highest close
$0.645 – $16.51 USDSince Mar 26, 2004 · lowest Sep 9, 2011 · highest Mar 30, 2006

Delisted NASDAQ:ANDS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ANDS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Stephen T Worland
Other companies: eFFECTOR Therapeutics Inc (Chief Executive Officer, Director · Aug 25, 2021 – May 15, 2024 · Past); GenMark Diagnostics Inc (Director · Jun 13, 2012 – May 29, 2014 · Past)
President and CEO, Director · Mar 2, 2006 – Dec 13, 2010 · Past
Steven H Holtzman
Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Biogen Inc. (EVP Corporate Development · Jan 4, 2011 – Feb 23, 2016 · Past)
Director · Jun 2, 2006 – May 28, 2010 · Past
James L Freddo
Other companies: InfuSystems Holdings, Inc. (Director · Apr 22, 2008 – Dec 3, 2010 · Past)
SVP, Drug Development and CMO, Director · Jul 10, 2006 – Jan 20, 2011 · Past
Jennifer K CrittendenVice President, Finance · Dec 8, 2006 – Dec 8, 2006 · Past
Kevin L EastwoodSVP, Corporate Development · Jan 3, 2011 – Jan 20, 2011 · Past
Marios FotiadisDirector · Jun 2, 2006 – May 27, 2011 · Past

Open People

Log in to ask 6ix AI your own questions about Anadys Pharmaceuticals Inc.